Market Insights Health Hospitals Inpatient Care

Treatment of Cardiovascular Diseases - Iraq

Iraq

The Treatment of Cardiovascular Diseases market in Iraq is expected to experience significant growth in the coming years.
According to projections, the revenue in this market is set to reach US$0.89bn in 2024.
This indicates a positive trend and highlights the growing importance of addressing cardiovascular diseases in the country.
Furthermore, it is anticipated that the market will continue to expand at an annual growth rate (CAGR 2024-2029) of 3.95%.
This steady growth is expected to contribute to a market volume of US$1.08bn by 2029.
These figures demonstrate the potential for continued development and investment in the treatment of cardiovascular diseases in Iraq.
When comparing the global landscape, it is noteworthy that in the United States is projected to generate the highest revenue in this market segment.
In 2024 alone, in the United States is expected to generate an impressive revenue of US$136.00bn.
This highlights the significant market presence and advanced healthcare infrastructure in the United States.
Overall, the Treatment of Cardiovascular Diseases market in Iraq is showing promising growth potential.
The projected revenue figures and global comparisons underscore the importance of addressing cardiovascular diseases and investing in their treatment within the country.
Iraq has seen a significant increase in the adoption of minimally invasive procedures for the treatment of cardiovascular diseases.

Key regions: China, India, United States, France, Canada

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.